DAKLI

DAKLI Struktur
118428-10-7
CAS-Nr.
118428-10-7
Englisch Name:
DAKLI
Synonyma:
DAKLI;Dynorphin A analog κ-ligand;DYNORPHIN A-ANALOG KAPPA LIGAND;DYNORPHIN A-ANALOGUE KAPPA LIGAND;(ARG11,13)-DYNORPHIN A (1-13)-GLY-NH-(CH2)5-NH2;TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-*PRO -ARG-LEU-AR;(ARG11,13)-DYNORPHIN A (1-13)-GLY-5-AMINO-PENTYLAMIDE;TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-PRO-ARG-LEU-ARG-GLY-NH-(CH2)5-NH2;H-TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-PRO-ARG-LEU-ARG-GLY-NH(CH2)5NH2;Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Arg-Leu-Arg-Gly 5-aminopentylamide
CBNumber:
CB8735083
Summenformel:
C82H141N31O15
Molgewicht:
1801.2
MOL-Datei:
118428-10-7.mol

DAKLI Eigenschaften

storage temp. 
-15°C

Sicherheit

DAKLI Chemische Eigenschaften,Einsatz,Produktion Methoden

DAKLI Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


DAKLI Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
GL Biochem (Shanghai) Ltd 21-61263452 13641803416
ymbetter@glbiochem.com China 9981 64
Nanjing Peptide Biotech Ltd. 025-025-58361106-805-805 13082558573
liugang@njpeptide.com China 9962 55
Nanjing Meihao Pharmaceutical Technology Co., Ltd. meitaochem@126.com
meitaochem@126.com China 19105 58

  • DYNORPHIN A-ANALOG KAPPA LIGAND
  • DYNORPHIN A-ANALOGUE KAPPA LIGAND
  • DAKLI
  • H-TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-PRO-ARG-LEU-ARG-GLY-5-AMINO-PENTYLAMIDE
  • H-TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-PRO-ARG-LEU-ARG-GLY-NH(CH2)5NH2
  • (ARG11,13)-DYNORPHIN A (1-13)-GLY-5-AMINO-PENTYLAMIDE
  • (ARG11,13)-DYNORPHIN A (1-13)-GLY-NH-(CH2)5-NH2
  • TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-PRO-ARG-LEU-ARG-GLY-NH-(CH2)5-NH2
  • TYR-GLY-GLY-PHE-LEU-ARG-ARG-ILE-ARG-*PRO -ARG-LEU-AR
  • Dynorphin A analog κ-ligand
  • Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Arg-Leu-Arg-Gly 5-aminopentylamide
  • 1-14-Dynorphin A (swine), 11-L-arginine-13-L-arginine-14-[N-(5-aminopentyl)glycinamide]- (9CI)
  • 118428-10-7
  • C82H141N31O15
Copyright 2019 © ChemicalBook. All rights reserved